RedHill Biopharma (RDHL) Return on Assets (2013 - 2024)
RedHill Biopharma (RDHL) posted quarterly Return on Assets of 0.03% for Q4 2024, up 4.0% year-over-year from 0.03% in Q1 2024, and up 29.96% quarter-over-quarter from 0.02% in Q2 2024.
RedHill Biopharma (RDHL) Return on Assets (2013 - 2024) Analysis & Trends
RedHill Biopharma (RDHL) has reported Return on Assets for 12 consecutive years, with 0.03% the latest figure, recorded in Q4 2024.
- In Q4 2024, Return on Assets rose 4.0% year-over-year to 0.03%; the TTM figure through Dec 2024 stood at 0.03% (up 4.0% YoY), while the FY2025 annual figure was 0.0%, up 1.0% from the prior year.
- Return on Assets grew to 0.03% in Q4 2024 per RDHL's latest filing, from 0.02% in the prior quarter.
- Across five years, Return on Assets topped out at 0.03% in Q4 2024 and bottomed at 0.01% in Q3 2022.
- Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2021.
- Annual changes were most pronounced in 2020 — Return on Assets decreased 1 bps — and 2024, when it grew 4 bps.
- RedHill Biopharma's Return on Assets stood at 0.0% in 2020, then tumbled by 295 bps to 0.01% in 2021, then rose by 12 bps to 0.0% in 2022, then tumbled by 41 bps to 0.01% in 2023, then jumped by 561 bps to 0.03% in 2024.
- Business Quant data shows RDHL's Return on Assets at 0.03% in Q4 2024, 0.02% in Q2 2024, and 0.01% in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 0.00% |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.03% |
| Jun 30, 2024 | 0.02% |
| Dec 31, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 0.01% |
| Sep 30, 2019 | 0.01% |
| Jun 30, 2019 | 0.01% |